Yunpeng Su

Title: The Innovations of Yunpeng Su

Introduction

Yunpeng Su is an accomplished inventor based in Katy, TX (US). He has made significant contributions to the field of biomedical research, particularly in the development of antibodies for medical applications. With a total of 2 patents, his work focuses on addressing critical health issues associated with abnormal angiogenesis.

Latest Patents

Yunpeng Su's latest patents include innovative antibodies targeting tumor endothelial marker 8 (TEM8). These antibodies and their fragments are designed for the detection, prevention, and treatment of diseases linked to abnormal angiogenesis. The inventions not only provide methods for identifying TEM8 in its native and cell-surface expressed forms but also introduce improved techniques for producing monoclonal antibodies. Additionally, pharmaceutical compositions and kits related to these antibodies are disclosed, showcasing the practical applications of his research.

Career Highlights

Throughout his career, Yunpeng Su has worked with prestigious organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and Scott & White Healthcare. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Yunpeng Su's notable coworkers include Arthur E Frankel and Brad St Croix. Their collaborative efforts have further advanced the research and development of innovative medical solutions.

Conclusion

Yunpeng Su's contributions to the field of biomedical research through his patents and collaborations highlight his commitment to improving healthcare. His work on antibodies targeting tumor endothelial marker 8 represents a significant advancement in the detection and treatment of diseases associated with abnormal angiogenesis.